TCM
PLRX icon

Tang Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Tang Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7M Sell
6,141,261
-1,871
-0% -$2.28K 0.32% 33
2026
Q1 		$7.74M Hold
6,143,132
– – 0.39% 29
2025
Q4 		$7.49M Buy
6,143,132
+139,686
+2% +$210K 0.37% 50
2025
Q3 		$8.89M Buy
6,003,446
+3,446
+0.1% +$5.26K 0.34% 68
2025
Q2 		$6.96M Hold
6,000,000
– – 0.35% 70
2025
Q1 		$8.1M Buy
+6,000,000
New +$36.4M 0.45% 54

Other funds holding PLRX

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Tang Capital Management's PLRX Position: Q2 2026 in Review

Tang Capital Management reduced its Pliant Therapeutics (PLRX) stake by 0.03% in Q2 2026, selling an estimated $2.28K and leaving 6,141,261 shares worth $7M. The position accounts for 0.32% of the portfolio, ranked #33.

Tang Capital Management first reported a position in PLRX in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.89M in Q3 2025. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Tang Capital Management held 6,141,261 shares of Pliant Therapeutics worth $7M as of Q2 2026.
  • Tang Capital Management sold 1,871 Pliant Therapeutics shares in Q2 2026, an estimated $2.28K.
  • Pliant Therapeutics made up 0.32% of Tang Capital Management's portfolio in Q2 2026, its #33 holding.
  • Tang Capital Management first reported a position in Pliant Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Tang Capital Management's Pliant Therapeutics position peaked at $8.89M in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.